Table 3. Average Monthly Medicaid Payments for HIV Patients by Protease Inhibitor Use
Research in Action, Issue 8
| CD4 cell count and cost | 1996 | 1997 | |||
|---|---|---|---|---|---|
| No protease inhibitor use | Protease inhibitor use | No protease inhibitor use | Protease inhibitor use | ||
| CD4 cell count less than 50 x 106 | Pharmacy cost | $487 | $852 | $508 | $745 |
| Total average cost | $2,047 | $1,704 | $2,805 | $1,814 | |
| CD4 cell count 50-200 x 106 | Pharmacy cost | $390 | $663 | $398 | $763 |
| Total average cost | $1,515 | $1,123 | $1,495 | $1,623 | |
| CD4 cell count 200-500 x 106 | Pharmacy cost | $267 | $455 | $299 | $652 |
| Total average cost | $1,036 | $780 | $1,395 | $1,031 | |
Note: Total average cost includes inpatient, outpatient, pharmacy, community care, and emergency room costs.
Source: Gebo KA, Chaisson RE, Folkemer JG, et al. Costs of HIV medical care in the era of highly active antiretroviral therapy. AIDS 1999; 13(8):963-9.


5600 Fishers Lane Rockville, MD 20857